Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 30, 2021
Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman PrimatesUttio Roy Chowdhury, Rachel A Kudgus, Bradley H Holman, et al.Nature Communications|December 7, 2017
The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligandJohn D Chan, Pauline M Cupit, Gihan S Gunaratne, et al.Investigative Ophthalmology & Visual Science|November 9, 2017
Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive AgentsUttio Roy Chowdhury, Tommy A Rinkoski, Cindy K Bahler, et al.Nature Microbiology|November 18, 2025
Structure-guided design of a synthetic bile acid that inhibits Clostridioides difficile TcdB toxinSean Miletic, Simoun Icho, Zhijie Li, et al.Organic Letters|June 18, 2004
Syntheses of syn and anti doublebent [5]phenyleneDennis T-Y Bong, Eugene W L Chan, Rainer Diercks, et al.Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agentsPeter I Dosa, Sonja Strah-Pleynet, Honnappa Jayakumar, et al.SLAS Discovery : Advancing Life Sciences R & D|August 22, 2024
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screeningRenee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.Journal of Medicinal Chemistry|August 6, 2010
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomniaYifeng Xiong, Brett Ullman, Jin-Sun Karoline Choi, et al.Journal of Medicinal Chemistry|May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosisYifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.Journal of Medicinal Chemistry|February 11, 2010
Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomniaBradley R Teegarden, Hongmei Li, Honnappa Jayakumar, et al.Pageof 5